510(k) K042808
K042808 is an FDA 510(k) premarket notification submitted by Bayer Healthcare, LLC for the device "ADVIA IMS CARBAMAZEPINE METHOD". The FDA issued a decision of Substantially Equivalent on February 8, 2005. The device falls under product code KLT (Enzyme Immunoassay, Carbamazepine), a Class II device regulated under 21 CFR 862.3645. Bayer Healthcare, LLC has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 8, 2005
- Date Received
- October 12, 2004
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Carbamazepine
- Device Class
- Class II
- Regulation Number
- 862.3645
- Review Panel
- TX
- Submission Type